• Pharmacokinetics: Pharmacokinetic

• Pharmacokinetics:
Pharmacokinetic:
Pharmacokinetic and pharmacodynamic studies showed that efalizumab produced saturation and 80% modulation of CD11a within 24 hours of therapy.
• Therapeutic Uses:
Survival of murine skin and heart allografts and monkey heart allografts, psoriasis, renal transplantation 4.

Results (Indonesian) 2:

• Farmakokinetik:
farmakokinetik:
. Studi farmakokinetik dan farmakodinamik menunjukkan bahwa efalizumab diproduksi saturasi dan 80% modulasi CD11a dalam waktu 24 jam terapi
• Terapi Penggunaan:
Kelangsungan Hidup kulit murine dan allografts jantung dan monyet allografts jantung, psoriasis, transplantasi ginjal 4.